GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Ray Co 228670.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

3,990

-0.99%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩111.32bn

FY2016FY2025

Net income

₩3.14bn

FY2016FY2025

Free cash flow

₩9.23bn

FY2016FY2025

Shareholders' equity

₩76.50bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩111.32bn₩79.84bn₩145.88bn₩129.00bn₩90.34bn₩55.20bn₩73.11bn₩51.53bn₩32.93bn₩26.50bn
Research and development₩6.28bn₩6.64bn₩6.99bn₩6.16bn₩5.06bn₩4.18bn₩3.18bn———
Operating income−₩9.79bn−₩48.36bn₩1.84bn₩16.21bn₩1.08bn₩4.58bn₩12.86bn₩6.05bn₩1.95bn₩1.32bn
Net income₩3.14bn−₩60.43bn−₩2.15bn₩7.96bn−₩12.8m₩7.90bn₩11.56bn₩5.25bn₩1.15bn₩1.71bn
Diluted earnings per share201.12-3,899.68-140.47567.80-0.96593.97868.39466.93108.07160.39

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩192.24bn₩204.22bn₩259.55bn₩222.20bn₩177.31bn₩89.20bn₩76.66bn₩41.27bn₩25.81bn₩24.34bn
Cash and short-term investments—₩27.69bn₩26.33bn₩28.51bn₩77.82bn₩27.94bn₩29.15bn₩12.21bn₩4.01bn₩5.49bn
Total liabilities₩117.44bn₩129.80bn₩128.36bn₩105.89bn₩76.59bn₩23.91bn₩19.12bn₩15.00bn₩11.12bn₩10.93bn
Debt₩672.0m₩80.65bn₩37.09bn₩49.58bn₩55.36bn₩9.01bn₩2.99bn₩3.40bn₩4.92bn₩4.60bn
Shareholders' equity₩76.50bn₩73.37bn₩127.27bn₩116.31bn₩100.72bn₩65.29bn₩57.53bn₩26.28bn₩14.69bn₩13.41bn
Shares outstanding16m15m15m14m13m13m13m11m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩12.85bn₩204.5m−₩22.79bn−₩8.23bn₩11.17bn₩2.90bn₩6.04bn₩4.30bn₩1.10bn₩582.0m
Capital spending−₩3.62bn−₩3.10bn−₩2.65bn−₩32.71bn−₩23.40bn−₩4.82bn−₩1.29bn−₩2.29bn−₩2.86bn−₩2.63bn
Free cash flow₩9.23bn−₩2.89bn−₩25.44bn−₩40.94bn−₩12.23bn−₩1.92bn₩4.75bn₩2.01bn−₩1.76bn−₩2.05bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩34.15bn₩25.67bn₩29.02bn₩30.33bn₩27.51bn₩24.46bn₩15.26bn₩22.47bn
Operating income₩5.65bn−₩3.42bn−₩8.34bn₩183.7m−₩1.85bn₩213.5m−₩24.77bn₩340.6m
Net income₩2.62bn₩2.95bn−₩9.80bn₩13.86bn−₩3.42bn₩2.50bn−₩36.39bn−₩2.10bn
Diluted earnings per share167.88189.36-628.27888.19-220.31161.18-2,345.92-135.23
Cash from operations₩4.48bn₩5.83bn₩12.79bn₩4.61bn−₩4.42bn−₩131.0m₩14.78bn₩7.44bn
Capital spending−₩120.0m−₩794.0m−₩693.0m−₩1.89bn−₩363.0m−₩670.0m−₩606.0m−₩1.10bn
Free cash flow₩4.36bn₩5.04bn₩12.10bn₩2.71bn−₩4.78bn−₩801.0m₩14.18bn₩6.33bn
Total assets₩177.24bn₩176.31bn₩192.24bn₩210.17bn₩202.90bn₩206.29bn₩204.22bn₩237.21bn
Cash and short-term investments—————₩27.77bn₩27.69bn₩23.77bn
Debt₩261.7m₩370.5m₩672.0m₩716.6m₩1.02bn₩80.27bn₩80.65bn₩75.10bn
Shareholders' equity₩81.30bn₩80.27bn₩76.50bn₩86.77bn₩73.26bn₩75.96bn₩73.37bn₩107.02bn

Financial ratios

Data as of 10 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin6.6%-67.5%1.3%12.6%1.2%8.3%
Net margin2.8%-75.7%-1.5%6.2%-0.0%14.3%
Return on equity4.1%-82.4%-1.7%6.8%-0.0%12.1%
Return on assets1.6%-29.6%-0.8%3.6%-0.0%8.9%
Revenue growth39.4%-45.3%13.1%42.8%63.6%-24.5%
Earnings growth-105.2%2715.4%-127.0%-62435.3%-100.2%-31.6%
Current ratio1.24x1.32x1.34x1.62x5.74x3.57x
Debt to equity0.01x1.06x0.25x0.39x0.51x0.12x
Equity ratio39.8%35.9%49.0%52.3%56.8%73.2%
Interest coverage1.13x-10.25x0.57x5.93x0.82x19.87x
R&D as a share of sales5.6%8.3%4.8%4.8%5.6%7.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.8%15.1%—
Net income-26.7%-16.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings33.7-1.5-162.742.1-29553.344.924.7
Price to sales0.91.12.42.64.26.43.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 3 Jun 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.